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Abstract
Background: Second-hand tobacco smoke has been associated with cardiopulmonary dys-
function. We sought to examine the residual effects of remote second-hand smoke exposure on
resting and exercise cardiopulmonary hemodynamics. We hypothesized that remote second-
hand smoke exposure results in persistent cardiopulmonary hemodynamic abnormalities.
Methods: Participants were non-smoking flight attendants who worked in airline cabins
prior to the in-flight tobacco ban. Participants underwent clinical evaluations and completed
smoke exposure questionnaires. We used Doppler echocardiography to measure pulmonary
artery systolic pressure (PASP) and pulmonary vascular resistance (PVR) at rest and during
supine bicycle ergometer exercise, using the validated formula TRV/VTIRVOT × 10 + 0.16, where
VTIRVOT is the velocity time integral at the right ventricular outflow tract and TRV is the tricuspid
regurgitation velocity. The group was divided into quartiles according to the degree of smoke
exposure. Analysis of variance was used to determine the differences in hemodynamic outcomes.
Results: Seventy-nine flight attendants were included in our analysis. Baseline characteristics
among participants in each quartile of smoke exposure were similar except for history of systemic
hypertension, which was more prevalent in the highest quartile. Peak exercise PASP rose to the
same degree in all test groups (mean PASP 44 mm Hg, p = 0.25), and PVR increased by
approximately 27% in all quartiles. There was no significant difference in pulmonary artery
systolic pressure or pulmonary vascular resistance among quartiles of smoke exposure.
Conclusions: We found that remote heavy second-hand smoke exposure from in-flight
tobacco is associated with systemic hypertension but does not have demonstrable pulmonary
hemodynamic consequences. (Cardiol J 2008; 15: 338–343)
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Introduction
Acute and chronic exposure to second-hand
tobacco smoke has been associated with cardiopul-
monary dysfunction including impaired endothelial
function, coronary artery disease and abnormal pul-
monary function [1–6]. However, some studies have
failed to show significant cardiopulmonary effects
of second-hand smoke exposure after adjusting for
potential confounding variables [7, 9]. While studies
using bicycle ergometry have demonstrated normal
cardiopulmonary hemodynamics in normal indivi-
duals and athletes and abnormal hemodynamics in
patients with chronic pulmonary diseases, cardiac
transplant, systemic lupus erythematosus and adults
with congenital heart diseases [10–13], no study has
examined cardiopulmonary hemodynamics in rela-
tion to remote second-hand smoke exposure.
Long-term residual effects of such exposure
are important because of concerns about the sub-
stantial numbers of individuals with a history of this
exposure. Among the populations most heavily
exposed to second-hand smoke were flight atten-
dants, who spent as much as 1000 hours per year
on commercial aircraft in contact with significant
second-hand smoke in a small, enclosed environ-
ment. Since the smoking ban on domestic commer-
cial flights in 1990 and on international flights in
1996, residual effects of remote in-flight tobacco
exposure have not been systematically examined.
The Flight Attendant Medical Research Institute
(FAMRI) was created to study the health effects of
second-hand smoke. While studies have shown that
former smokers have a persistent decrease in exer-
cise capacity compared with non-smokers [14], the
effects of remote second-hand smoke exposure on
cardiopulmonary function is unknown.
Therefore, we sought to examine the effects
of remote second-hand smoke exposure on residu-
al baseline or exercise cardiopulmonary hemody-
namics. We hypothesized that remote in-flight se-
cond-hand smoke exposure results in persistent
abnormalities in cardiopulmonary hemodynamics in
proportion to the degree of exposure.
Methods
Participants
Participants were flight attendants recruited by
the FAMRI clinic at the University of California, San
Francisco, an outpatient clinic which performs car-
diopulmonary evaluations in flight attendants expo-
sed to second-hand smoke. The study was adverti-
sed through local newspapers, flight attendants’
union meetings, email distributions and announce-
ments at airport symposia. Flight attendants were
screened for initial eligibility based on established
inclusion and exclusion criteria. Inclusion criteria
were (1) second-hand smoke exposure ≥ 5 years
while working as a flight attendant, and (2) the abi-
lity to perform supine bicycle ergometry. Exclusion
criteria were (1) personal history of smoking, (2) hi-
story of clinically overt cardiac disease, including
stable or unstable angina; coronary artery disease
(defined as abnormal stress test, cardiac catheteri-
zation showing ≥ 70% coronary artery stenosis, hi-
story of revascularization, pathologic Q waves on
EKG); congestive heart failure (defined as left ven-
tricular ejection fraction < 55%; physical exam fin-
dings of coronary heart failure; symptomatic pulmo-
nary oedema); moderate to severe valvular heart
disease; and congenital heart disease; (3) history of
clinically overt pulmonary disease, including asth-
ma, recent-onset bronchitis, chronic interstitial lung
disease, obstructive sleep apnea, collagen vascular
disease requiring chronic steroid or immune mo-
dulating therapy and pulmonary hypertension;
(4) history of significant second-hand smoke expo-
sure at home; (5) physical inability to perform su-
pine bicycle exercise testing, including: paralysis,
weakness, amputation or symptomatic arthritis of the
lower extremities, disabling back pain; and (6) inabi-
lity to obtain adequate echocardiographic images due
to technical reasons.
A total of 282 participants were screened, from
which 130 participants were eligible and agreed to
participate. From this sample, 20 participants were
excluded after careful review of history and physi-
cal examination (6 for personal smoking history,
1 for severe resting hypertension, 4 for asthma,
6 for recent-onset bronchitis, 2 for collagen vascu-
lar disease, 1 for obstructive sleep apnea, and 1 for
moderate aortic regurgitation). Supine bicycle er-
gometry was not performed on 24 participants due
to patient availability and they were thus excluded.
We also excluded 7 male participants since the ma-
jority of participants were female. These exclusions
resulted in a sample of 79 female participants.
The study was approved by the institutional




The predictor variable, expressed as hour-
years, is the degree of second-hand occupational
smoke exposure based on a detailed questionnaire
regarding in-flight smoke exposure. The question-
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naire was stratified by decade and included number
of years flown and number of hours per month flown.
Outcome variables:
Resting and exercise hemodynamics
We performed resting and stress echocardio-
grams using an Acuson Sequoia Ultrasound System
(Mountain View, California) with a 3.5-MHz trans-
ducer. Before exercise, standard 2-dimensional
parasternal short-axis, apical 2- and 4-chamber, and
subcostal views obtained during breath-hold were
planimetered using a computerized digitization sys-
tem to determine end-systolic and end-diastolic left
ventricular volume, left ventricular ejection fraction
and left ventricular mass. Left ventricular ejection
fraction was measured quantitatively using the
2-D echocardiography biplane method of discs [15, 16].
Left ventricular mass index was calculated based
on the 2-D echocardiography truncated ellipse me-
thod [17]. In the parasternal short-axis view, pulse
wave Doppler was used to determined the right
ventricular outflow tract (RVOT) velocity time in-
tegral (VTI). In the apical 4-chamber view, conti-
nuous wave Doppler was used to determine the
maximal tricuspid regurgitation velocity (TRV).
Intravenous agitated saline (5 to 10 ml isotonic sa-
line) was used in all participants to enhance the
Doppler-derived tricuspid regurgitation jet. Left
ventricular contrast was used to enhance 2-D echo-
cardiographic images when deemed necessary by
the supervising physician. The maximum tricuspid
regurgitation gradient (in mm Hg) was estimated
(DP = 4V2) by modification of the Bernoulli formu-
la. Pulmonary artery systolic pressure (PASP) was
computed as the sum of the tricuspid regurgitation
gradient and right atrial pressure [13, 18]. Pulmo-
nary vascular resistance (PVR) was calculated using
the validated formula TRV/VTIRVOT × 10 + 0.16 [19].
A symptom-limited, graded exercise supine
bicycle ergometry test was performed. A variable-
load supine bicycle ergometer (Medical Positioning
Inc. Q-Stress Echo Bed, Indianapolis, IN) was used
for all testing with the ergometer table tilted to 20o
(patient’s left side down) to obtain the standard
echocardiographic apical views. Patients pedalled
at a constant speed, beginning at a workload of
10 W and increasing by 30 W every 3-min stage until
reaching symptom-limiting fatigue. Heart rate, cuff
blood pressure, pulse oximetry, segmental ventri-
cular wall motion, right ventricular outflow tract
velocity time integral and maximum tricuspid regur-
gitation velocity were recorded at rest, at each sta-
ge of exercise and after four minutes of recovery.
Continuous 2-lead electrocardiogram and pulse oxi-
metry were monitored throughout exercise. A single
cardiologist (N.B.S.), blinded to clinical and laborato-
ry information, evaluated all of the echocardiograms.
Resting and exercise pulmonary
function tests
On the same day, complete resting and exer-
cise pulmonary function testing (including diffusing
capacity, ventilatory equivalents and oxygen con-
sumption) were conducted, based on the methodo-
logy described previously [20–27]. Pulmonary func-
tion data will form the subject of another commu-
nication.
Other characteristics
Each participant completed an additional deta-
iled questionnaire that included age, sex, medical
history, medication history and occupation history.
The questionnaire is available at www.tobac-
co.ucsf.edu. The level of functional capacity was
assessed by the Duke Activity Status Index: a sim-
ple 12-item yes/no questionnaire which has been
validated in various cardiopulmonary disease sta-
tes [28–31]. Study personnel recorded current
medications, height, weight and blood pressure.
Statistical analysis
Smoke exposure was classified into four quar-
tiles, as lowest 25%, 25–50%, 50–75% and highest
75%. Analysis of variance was used to determine
the differences in hemodynamic outcomes on the
means for continuous variables and the proportions
for dichotomous variables. We reported all data with
95% confidence intervals (CI). Analyses were perfor-
med using Statistical Analysis Software (Version 9,
SAS Institute Inc, Cary, NC).
Results
Baseline characteristics among participants in
each quartile of total smoke exposure are listed in
Table 1. The mean age was 59 years and all parti-
cipants were female. Compared with participants
in the lower quartiles, those in the upper quarti-
les were more likely to have a history of hyper-
tension. The upper quartiles of smoke exposure
trended toward greater use of diuretics and hor-
mone replacement therapy, although these were
not statistically significant. The highest quartile of
exposure had nearly 50% hormone replacement
use. The upper quartiles of smoke exposure also
trended toward higher Duke Activity Status Index,
although this trend was not statistically signifi-
cant. The mean resting PASP and PVR among all
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participants were 21 mm Hg and 1.5 Wood units,
respectively. There was no significant difference
in resting blood pressure, heart rate, left ventri-
cular mass index, PASP or PVR.
With exercise, there was no significant diffe-
rence in blood pressure response, heart rate re-
sponse or double product among the quartiles of
exposure (Table 2). The intensity of exercise was
adequate as judged by the achieved double product.
The PASP at peak stress (mean 44 mm Hg among
all participants) approximately doubled in all qu-
artiles of exposure and did not differ statistically.
Table 1. Baseline characteristics.
Quartiles of total smoke exposure p
1st quartile 2nd quartile 3rd quartile 4th quartile
(n = 19) (n = 20) (n = 19) (n = 21)
Age (years) 56 57 58 60 0.29
History of hypertension (%) 5 5 26 33 0.03
History of diabetes (%) 5 5 5 0 0.78
History of hyperlipidemia (%) 32 25 42 33 0.74
History of sinus problem (%) 11 20 16 19 0.86
Duke activity index 12.6 14.5 15.2 15.3 0.07
Medication use:
   Beta-blockers (%) 0 0 0 0 NA
   Diuretic (%) 0 0 11 19 0.06
   Hormone replacement (%) 16 35 16 48 0.07
Vitamins (%) 53 65 58 48 0.73
Resting SBP [mm Hg] 125 119 133 127 0.17
Resting DBP [mm Hg] 70 72 73 70 0.82
Resting heart rate (bpm) 70 69 67 67 0.82
Left ventricular mass index [g/m2] 73 72 75 67 0.36
Resting PASP [mm Hg] 21 19 22 21 0.20
Resting RVOT VTI [cm] 17.5 15.9 17.9 17.0 0.23
Resting PVR [Wood units] 1.5 1.5 1.5 1.5 0.93
SBP — systolic blood pressure; DBP — diastolic blood pressure; RVOT — right ventricular outflow tract; VTI — velocity time integral;
PASP — pulmonary artery systolic pressure; PVR — pulmonary vascular resistance
Table 2. Exercise data.
Quartiles of total smoke exposure p
1st quartile 2nd quartile 3rd quartile 4th quartile
(n = 19) (n = 20) (n = 19) (n = 21)
Peak SBP [mm Hg] 182 176 183 186 0.44
Peak DBP [mm Hg] 91 92 86 84 0.07
Peak heart rate [bpm] 153 154 150 148 0.37
Exercise duration [s] 918 865 848 843 0.46
Double product (HR × SBP) 27873 27067 27484 27455 0.93
Peak PASP [mm Hg] 46 42 44 46 0.25
DPASP [mm Hg] 25 23 22 25 0.69
Peak RVOT VTI [cm] 19.5 18.6 21.9 19.6 0.61
Peak PVR [Wood units] 1.9 1.9 1.9 1.9 0.85
DPVR [Wood units] 0.4 0.4 0.4 0.4 0.93
Wall motion abnormality 0 0 0 0 NA
SBP — systolic blood pressure; DBP — diastolic blood pressure; HR — heart rate; RVOT — right ventricular outflow tract; VTI — velocity time
integral; PASP — pulmonary artery systolic pressure; PVR — pulmonary vascular resistance; NA — not available
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The PVR at peak stress (mean 1.9 Wood units
among all participants) increased by approximately
27% in all quartiles without statistical difference.
There was no evidence of stress-induced ST-seg-
ment depression or segmental wall motion abnor-
mality on echocardiography in any participant.
Discussion
We found that the degree of remote heavy se-
cond-hand smoke exposure from in-flight tobacco
is associated with treated systemic hypertension
but does not have demonstrable residual pulmona-
ry or systemic hemodynamic consequences. Pre-
vious studies have not found an association of chro-
nic passive smoke exposure with hypertension [4, 32].
While acute second-hand smoke exposure can cau-
se hypertension through increased norepinepheri-
ne, epinephrine, endothelin-1, carboxyhemoglobin
and other cigarette constituents [4, 33–37], our
population was remotely exposed. Thus chronical-
ly altered vascular reactivity from remote chronic
intense smoke exposure may have been mechani-
stically related to the increased prevalence of sys-
temic hypertension. However, since smoke expo-
sure was associated with flight time, factors such
as time spent at high altitude, circadian rhythm distur-
bance and emotional stress may be contributory.
Baseline and exercise PASP in our study po-
pulation are similar to historic controls [13, 38, 39].
Similarly, baseline PVR in our patient population is
within the normal range [40]. Furthermore, the
response of PVR to exercise is similar to that of
conditioned athletes [39]. These findings suggest
that in-flight smoke exposure either had no signifi-
cant cardiopulmonary effects or may have had car-
diopulmonary effects that have since dissipated.
These findings are reassuring in that they imply
a potential for cardiopulmonary recovery after expo-
sure has stopped.
We believe that the unique features of this stu-
dy include its large sample size and its focus on the
association of significant remote second-hand smo-
ke exposure on resting and exercise cardiopulmo-
nary hemodynamics. Nonetheless, several limita-
tions must be considered when interpreting these
results. First, our participants were former or cur-
rent flight attendants recruited from the FAMRI
clinic, an outpatient clinic specifically targeted to
the health care issues of flight attendants exposed
to second-hand smoke. These participants were
health conscious, which may have resulted in sam-
pling bias. However, despite this potential bias to-
ward a positive finding, we did not find any signifi-
cant cardiopulmonary hemodynamic differences
among the four quartiles of exposure. Conversely,
remote passive smoke could have caused severe
impairment such as early sequele of advanced chronic
obstructive pulmonary disease or death, favouring
a negative finding. In addition, people who partici-
pate in clinical studies are generally healthier than
the average population. Second, flight hours and
perceived intensity of smoke are by self-report,
which can result in reporting bias. A previous study
has shown consistent self over-reporting of flight
time when compared with company records [41].
Third, second-hand smoke exposure may be asso-
ciated with cardiopulmonary damage not detected
by hemodynamic measurements. Finally, our par-
ticipants were exclusively female flight attendants,
and our results may not be applicable to men.
Conclusions
We found that the degree of remote heavy se-
cond-hand smoke exposure from in-flight tobacco
is associated with a history of systemic hyperten-
sion but does not have demonstrable pulmonary or
systemic hemodynamic consequences or inducible
ischemia. Whether this lack of association is due to
a lack of causal relationship or recovery from prior
impairment merits further study.
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